MARKET OVERVIEW

The Europe veterinary healthcare market reached USD 2,055.29 Million in 2024 and is expected to grow to USD 3,753.21 Million by 2033, exhibiting a CAGR of 6.92% during the forecast period 2025–2033. The sector growth is driven by rising pet ownership, increasing livestock population, technological advancements in veterinary care, stringent EU animal welfare regulations, and a growing demand for specialized veterinary services to ensure animal health and food safety.

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Years: 2019-2024

EUROPE VETERINARY HEALTHCARE MARKET KEY TAKEAWAYS

• Current Market Size: USD 2,055.29 Million (2024)
• CAGR: 6.92%
• Forecast Period: 2025-2033
• Europe has more than 90 million pet-owning families, driving demand for veterinary services, pharmaceuticals, and specialized treatments.
• Humanization of pets is boosting expenditure on advanced veterinary health services such as vaccination and orthopedic procedures.
• Germany, France, and the UK lead in veterinary healthcare expenditure due to rising disposable incomes and insurance coverage.
• The European pet insurance market is expanding, with Sweden having close to 90% of dogs insured, encouraging more complex treatments.
• Technological innovations such as AI-powered diagnostics, telemedicine, and minimally invasive surgeries are enhancing veterinary care efficiency.

Sample Request Link: https://www.imarcgroup.com/europe-veterinary-healthcare-market/requestsample

MARKET GROWTH FACTORS

The Europe veterinary healthcare market is driven by the rise in pet ownership. The European Pet Food Federation (FEDIAF) made a 2020 estimate about around 90 million European homes having a pet, so veterinary pharmaceuticals and advanced therapies are more in demand. Furthermore, humans have anthropomorphized their pets to thereby increase spending on preventive care, vaccination, orthopedic procedures, and dental care.

The veterinary healthcare market has also grown because of technology advances like veterinary diagnostics, telemedicine, AI imaging, and minimally intrusive surgical techniques. Examples include AI tools for image analysis in order to diagnose disease in livestock and pets, pet wearables, and mobile veterinary clinics that increase access to veterinary services.

PLF technologies in the livestock sector better manage animal health and improve disease control to reduce the need for antibiotics. EU veterinary regulations restricting antibiotic use in livestock enacted in 2022 created demand for alternatives such as probiotics, vaccines, and early disease diagnosis. Corporate veterinary chains like AniCura and CVS Group grow toward investment in medical technology. Investment occurs in MRI (magnetic resonance imaging) scanners, robotic surgery, and 3D printed prosthetics.

MARKET SEGMENTATION

Product Insights:

• Therapeutics
• Vaccines
• Parasiticides
• Anti-infectives
• Medical Feed Additives
• Others
• Diagnostics
• Immunodiagnostic Tests
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Chemistry
• Others

The product segmentation covers therapeutics and diagnostics. Therapeutics include vaccines, parasiticides, anti-infectives, medical feed additives, and others. Diagnostics cover immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and others.

Animal Type Insights:

• Dogs and Cats
• Horses
• Ruminants
• Swine
• Poultry
• Others

Animal type segmentation covers dogs and cats, horses, ruminants, swine, poultry, and other animals.

Country-Wise Insights:

• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

The market is analyzed across major European countries including Germany, France, the United Kingdom, Italy, Spain, and others.

REGIONAL INSIGHTS

Germany, France, and the United Kingdom are the dominant regions in the Europe veterinary healthcare market. These countries lead expenditure due to rising disposable incomes and expanding pet insurance coverage. For example, Sweden has nearly 90% dog insurance coverage, setting a benchmark for other regions. This growing financial support enables more advanced and complex veterinary treatments.

RECENT DEVELOPMENTS & NEWS

In November 2024, Scandinavian ChemoTech's Animal Care sold its vetIQure™ TSE device with treatment kits to the German veterinary practice Christoph Sonntag, specializing in domestic animal treatment, highlighting new collaboration in Europe. In July 2024, European private equity firm Inflexion acquired German veterinary practice group Tierarzt Plus Partner (TPP) for over €300 million, marking Inflexion's fourth investment in the animal health sector and signaling strong investor interest.

KEY PLAYERS

• AniCura (Sweden)
• CVS Group (UK)
• Scandinavian ChemoTech's Animal Care
• Tierarzt Plus Partner (TPP)
• Inflexion

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.